Marsha Guess
Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pelvic Organ Prolapse | 12 | 2023 | 41 | 3.630 |
Why?
| Urinary Incontinence | 4 | 2019 | 60 | 1.690 |
Why?
| Bicycling | 4 | 2014 | 80 | 1.520 |
Why?
| Pelvic Floor | 4 | 2021 | 27 | 1.500 |
Why?
| Genitalia, Female | 6 | 2017 | 40 | 1.350 |
Why?
| Sexual Dysfunction, Physiological | 5 | 2017 | 60 | 1.280 |
Why?
| Postpartum Period | 2 | 2019 | 281 | 1.050 |
Why?
| Pelvic Floor Disorders | 3 | 2022 | 10 | 0.970 |
Why?
| Vibration | 4 | 2017 | 74 | 0.780 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 1213 | 0.690 |
Why?
| Constipation | 1 | 2019 | 75 | 0.680 |
Why?
| Lower Urinary Tract Symptoms | 1 | 2019 | 47 | 0.670 |
Why?
| Ligaments | 6 | 2023 | 48 | 0.660 |
Why?
| Physical Examination | 1 | 2019 | 253 | 0.630 |
Why?
| Vagina | 5 | 2016 | 167 | 0.610 |
Why?
| Electric Stimulation Therapy | 1 | 2017 | 75 | 0.570 |
Why?
| Uterus | 5 | 2020 | 197 | 0.550 |
Why?
| Puerperal Disorders | 1 | 2013 | 34 | 0.450 |
Why?
| Body Mass Index | 3 | 2015 | 2144 | 0.440 |
Why?
| Fecal Incontinence | 3 | 2022 | 76 | 0.430 |
Why?
| Surgery, Plastic | 1 | 2012 | 28 | 0.420 |
Why?
| Sensation | 3 | 2012 | 46 | 0.410 |
Why?
| Pregnancy | 4 | 2019 | 5854 | 0.370 |
Why?
| Sacrum | 4 | 2020 | 63 | 0.360 |
Why?
| Recovery of Function | 1 | 2013 | 610 | 0.350 |
Why?
| Clitoris | 2 | 2006 | 9 | 0.310 |
Why?
| Female | 30 | 2023 | 63629 | 0.310 |
Why?
| Cross-Sectional Studies | 6 | 2019 | 4734 | 0.300 |
Why?
| Adult | 16 | 2019 | 32385 | 0.290 |
Why?
| Young Adult | 6 | 2019 | 11094 | 0.280 |
Why?
| Homeodomain Proteins | 4 | 2012 | 484 | 0.270 |
Why?
| Sexual Behavior | 3 | 2017 | 470 | 0.240 |
Why?
| Running | 1 | 2006 | 233 | 0.240 |
Why?
| Consensus | 3 | 2022 | 554 | 0.240 |
Why?
| Humans | 31 | 2023 | 122796 | 0.220 |
Why?
| Middle Aged | 13 | 2020 | 28563 | 0.210 |
Why?
| Suburethral Slings | 2 | 2013 | 5 | 0.210 |
Why?
| Perineum | 2 | 2012 | 29 | 0.210 |
Why?
| Pelvis | 2 | 2016 | 94 | 0.210 |
Why?
| Delivery, Obstetric | 3 | 2015 | 134 | 0.200 |
Why?
| Uterine Prolapse | 4 | 2009 | 14 | 0.200 |
Why?
| Equipment Design | 2 | 2014 | 533 | 0.200 |
Why?
| Hysterectomy | 3 | 2013 | 119 | 0.190 |
Why?
| Cesarean Section | 3 | 2013 | 184 | 0.190 |
Why?
| Receptors, Estrogen | 1 | 2023 | 388 | 0.190 |
Why?
| Sexual Dysfunctions, Psychological | 3 | 2012 | 31 | 0.190 |
Why?
| Surveys and Questionnaires | 5 | 2022 | 4882 | 0.180 |
Why?
| Pelvic Pain | 1 | 2019 | 38 | 0.180 |
Why?
| Orgasm | 1 | 2017 | 6 | 0.160 |
Why?
| Health Surveys | 1 | 2019 | 468 | 0.160 |
Why?
| Radiology | 1 | 2021 | 203 | 0.150 |
Why?
| Models, Animal | 2 | 2016 | 373 | 0.140 |
Why?
| Prospective Studies | 4 | 2020 | 6704 | 0.140 |
Why?
| Logistic Models | 2 | 2019 | 1995 | 0.140 |
Why?
| Connecticut | 1 | 2015 | 22 | 0.140 |
Why?
| Surgical Mesh | 2 | 2013 | 40 | 0.130 |
Why?
| Risk Factors | 4 | 2020 | 9381 | 0.130 |
Why?
| Trial of Labor | 1 | 2013 | 14 | 0.120 |
Why?
| Urinary Incontinence, Stress | 1 | 2013 | 14 | 0.120 |
Why?
| Consumer Product Safety | 1 | 2013 | 33 | 0.120 |
Why?
| Women's Health | 2 | 2006 | 277 | 0.110 |
Why?
| Libido | 1 | 2012 | 23 | 0.110 |
Why?
| China | 1 | 2013 | 223 | 0.110 |
Why?
| Ovariectomy | 1 | 2012 | 125 | 0.110 |
Why?
| Endometrial Neoplasms | 1 | 2013 | 144 | 0.100 |
Why?
| Adolescent | 2 | 2019 | 18948 | 0.100 |
Why?
| Pressure | 1 | 2011 | 248 | 0.090 |
Why?
| Birth Weight | 1 | 2013 | 473 | 0.090 |
Why?
| Rectovaginal Fistula | 1 | 2009 | 10 | 0.090 |
Why?
| Rectal Diseases | 1 | 2009 | 16 | 0.090 |
Why?
| Health Care Costs | 1 | 2013 | 414 | 0.090 |
Why?
| Biopsy | 1 | 2013 | 1090 | 0.090 |
Why?
| Pregnancy, Ectopic | 1 | 2009 | 54 | 0.090 |
Why?
| Abscess | 1 | 2009 | 74 | 0.090 |
Why?
| Early Detection of Cancer | 1 | 2013 | 364 | 0.080 |
Why?
| Cicatrix | 1 | 2009 | 54 | 0.080 |
Why?
| Aged | 5 | 2015 | 20495 | 0.080 |
Why?
| Aged, 80 and over | 2 | 2015 | 6845 | 0.070 |
Why?
| Smoking | 1 | 2013 | 1556 | 0.070 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2009 | 466 | 0.070 |
Why?
| Reference Values | 1 | 2006 | 789 | 0.060 |
Why?
| Genital Diseases, Female | 1 | 2005 | 29 | 0.060 |
Why?
| Urologic Surgical Procedures | 1 | 2005 | 93 | 0.060 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2004 | 27 | 0.060 |
Why?
| Prostheses and Implants | 1 | 2005 | 145 | 0.060 |
Why?
| Fibroblasts | 1 | 2009 | 846 | 0.060 |
Why?
| Age Factors | 1 | 2012 | 3114 | 0.060 |
Why?
| Follow-Up Studies | 1 | 2013 | 4768 | 0.060 |
Why?
| Estrogen Receptor beta | 1 | 2023 | 36 | 0.060 |
Why?
| Ultrasonography | 2 | 2021 | 740 | 0.060 |
Why?
| Multivariate Analysis | 1 | 2006 | 1531 | 0.050 |
Why?
| Estrogen Receptor alpha | 1 | 2023 | 126 | 0.050 |
Why?
| Receptors, Androgen | 1 | 2023 | 136 | 0.050 |
Why?
| Infant, Newborn | 1 | 2013 | 5430 | 0.050 |
Why?
| Public Opinion | 1 | 2022 | 60 | 0.050 |
Why?
| Menopause | 1 | 2005 | 270 | 0.050 |
Why?
| Cell Proliferation | 1 | 2009 | 2328 | 0.050 |
Why?
| Postoperative Complications | 1 | 2012 | 2301 | 0.050 |
Why?
| Radiography, Abdominal | 1 | 2021 | 33 | 0.050 |
Why?
| Estrogens | 1 | 2023 | 325 | 0.050 |
Why?
| Child | 1 | 2019 | 19561 | 0.050 |
Why?
| Mice, Inbred C57BL | 3 | 2016 | 5020 | 0.040 |
Why?
| NIH 3T3 Cells | 2 | 2009 | 141 | 0.040 |
Why?
| Case-Control Studies | 2 | 2020 | 3296 | 0.040 |
Why?
| Research Design | 1 | 2004 | 1002 | 0.040 |
Why?
| Endothelial Cells | 1 | 2023 | 749 | 0.040 |
Why?
| Connective Tissue | 1 | 2016 | 38 | 0.040 |
Why?
| Muscle, Smooth | 1 | 2016 | 159 | 0.030 |
Why?
| Sensory Thresholds | 2 | 2005 | 31 | 0.030 |
Why?
| Mice | 4 | 2016 | 15888 | 0.030 |
Why?
| Aging | 1 | 2005 | 1694 | 0.030 |
Why?
| Device Approval | 1 | 2013 | 24 | 0.030 |
Why?
| Decision Trees | 1 | 2013 | 95 | 0.030 |
Why?
| Gelatinases | 1 | 2012 | 6 | 0.030 |
Why?
| Matrix Metalloproteinases, Secreted | 1 | 2012 | 10 | 0.030 |
Why?
| Collagen Type III | 1 | 2012 | 21 | 0.030 |
Why?
| Enzyme Precursors | 1 | 2012 | 26 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2020 | 2784 | 0.030 |
Why?
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 25 | 0.030 |
Why?
| Phenotype | 1 | 2020 | 3070 | 0.030 |
Why?
| Nervous System Diseases | 2 | 2005 | 265 | 0.030 |
Why?
| Collagen Type I | 1 | 2012 | 113 | 0.030 |
Why?
| Health Care Surveys | 1 | 2013 | 564 | 0.020 |
Why?
| Gene Knockdown Techniques | 1 | 2012 | 322 | 0.020 |
Why?
| United States | 2 | 2021 | 13272 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2016 | 2501 | 0.020 |
Why?
| Cohort Studies | 1 | 2020 | 5294 | 0.020 |
Why?
| Cost-Benefit Analysis | 1 | 2013 | 573 | 0.020 |
Why?
| Pilot Projects | 2 | 2005 | 1477 | 0.020 |
Why?
| Rectocele | 1 | 2009 | 3 | 0.020 |
Why?
| Ischium | 1 | 2009 | 10 | 0.020 |
Why?
| Animals | 4 | 2016 | 34133 | 0.020 |
Why?
| Uterine Artery Embolization | 1 | 2009 | 7 | 0.020 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 2009 | 21 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2021 | 3264 | 0.020 |
Why?
| Uterine Hemorrhage | 1 | 2009 | 36 | 0.020 |
Why?
| Societies, Medical | 1 | 2013 | 741 | 0.020 |
Why?
| Chorionic Gonadotropin | 1 | 2009 | 81 | 0.020 |
Why?
| Prolapse | 1 | 2008 | 5 | 0.020 |
Why?
| Self Report | 1 | 2012 | 730 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 1855 | 0.020 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2008 | 57 | 0.020 |
Why?
| Methotrexate | 1 | 2009 | 227 | 0.020 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2008 | 131 | 0.020 |
Why?
| Rats | 1 | 2016 | 5426 | 0.020 |
Why?
| Polypropylenes | 1 | 2005 | 19 | 0.020 |
Why?
| Anus Diseases | 1 | 2005 | 8 | 0.020 |
Why?
| Collagen | 1 | 2008 | 436 | 0.020 |
Why?
| Touch | 1 | 2005 | 33 | 0.020 |
Why?
| Nervous System | 1 | 2005 | 67 | 0.020 |
Why?
| Anal Canal | 1 | 2005 | 83 | 0.020 |
Why?
| Practice Patterns, Physicians' | 1 | 2013 | 1267 | 0.020 |
Why?
| International Cooperation | 1 | 2004 | 182 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2008 | 1727 | 0.010 |
Why?
| Retrospective Studies | 2 | 2013 | 13433 | 0.010 |
Why?
| Cells, Cultured | 1 | 2009 | 4162 | 0.010 |
Why?
| RNA, Messenger | 1 | 2008 | 2720 | 0.010 |
Why?
| Evidence-Based Medicine | 1 | 2004 | 731 | 0.010 |
Why?
| Comorbidity | 1 | 2005 | 1600 | 0.010 |
Why?
| Diabetes Mellitus | 1 | 2005 | 985 | 0.010 |
Why?
| Practice Guidelines as Topic | 1 | 2004 | 1519 | 0.010 |
Why?
| Male | 1 | 2013 | 59639 | 0.000 |
Why?
|
|
Guess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|